Menu
Menu
YUTIQ is designed to deliver treatment for up to 36 months
See an innovation in uveitis treatment. YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg is designed to provide lasting treatment up to 36 months through everything you want to see. YUTIQ is a single-injection treatment for patients with chronic non-infectious uveitis affecting the back of the eye (posterior segment uveitis).
YUTIQ is designed to deliver treatment for up to 36 months, providing continuous calm with less inflammation. You may also have fewer injection appointments.
If you have any posterior uveitis symptoms, find a retina or uveitis specialist near you to talk to, or ask your eye doctor if treatment with YUTIQ would be right for you.
*People pictured are not real patients unless otherwise noted.
YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.
Do not take YUTIQ if:
YUTIQ may cause serious side effects, including:
Injection-related effects, steroid-related effects and movement of the implant.
Call your doctor if your eye becomes red, sensitive to light, painful or if your vision changes or becomes blurred.
You may experience temporary blurred vision. Do not drive or use machines until your vision clears.
The most common side effects in the eye were cataract and reduced clarity of vision. The most common side effects not related to the eye were upper respiratory infection, high blood pressure and joint pain.
If you are pregnant, become pregnant or consider breastfeeding after having received YUTIQ inform your doctor immediately.
Please see full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
YUTIQ, the YUTIQ logo, and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc. EyePoint Assist is a service mark of EyePoint Pharmaceuticals, Inc.
©2022 EyePoint Pharmaceuticals, Inc. All rights reserved.
480 Pleasant Street, Suite B300, Watertown, MA 02472
12/2022
US-YUT-2200116
YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.
Do not take YUTIQ if:
